An Open Label Randomized Controlled Trial To Compare Plasma Removal Efficacy As Well As Cost Of Therapeutic Plasma Exchange By Two Different Technologies (Centrifugal Vs Membranous) In Nephrology Patients

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.No evidence of active infection
•2.Willing to give informed consent for the procedure (In patients who are incompetent to consent, consent shall be taken from the surrogate)
•3.Those who not enrolled in any other study

•1.Pregnancy
•2.Microbiological or radiological evidence of active infection
•3.Known allergy to Plasma, Protamine or Heparin.
•4.Severe systemic illness like HIV
•5.Patients with vasculitis due to secondary causes (diagnosis of a different rheumatic disease, Hepatitis B, Hepatitis C, HIV infection)
•6.Mechanically ventilated patients
•7.Renal or any other Transplant recipient will be excluded

发起方

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH